1 - 3 toradh á dtaispeáint as 3 toradh san iomlán ar an gcuardach 'Arbetter, D', am iarratais: 0.02s Beachtaigh na torthaí
  1. 1
    Outpatient treatment with AZD7442 (tixagevimab/cilgavimab) prevented Covid-19 hospitalizations over 6 months and reduced symptom progression in the TACKLE randomized trial

    Outpatient treatment with AZD7442 (tixagevimab/cilgavimab) prevented Covid-19 hospitalizations over 6 months and reduced symptom progression in the TACKLE randomized trial de réir Hobbs, FDR, Montgomery, H, Padilla, F, Simón-Campos, JA, Kim, K, Arbetter, D, Padilla, KW, Reddy, VP, Seegobin, S, Streicher, K, Templeton, A, Viani, RM, Johnsson, E, Koh, GCKW, Esser, MT

    Foilsithe / Cruthaithe 2023
    Journal article
  2. 2
    Analysis of SARS-CoV-2 Emergent variants following AZD7442 (tixagevimab/cilgavimab) for early outpatient treatment of COVID-19 (TACKLE trial)

    Analysis of SARS-CoV-2 Emergent variants following AZD7442 (tixagevimab/cilgavimab) for early outpatient treatment of COVID-19 (TACKLE trial) de réir Kijak, GH, Ahani, B, Arbetter, D, Chuecos, F, Gopalakrishnan, V, Beloor, J, Brady, T, Nguyen, A, Roe, TL, Schuko, N, Zhang, T, Hobbs, FDR, Padilla, F, Kelly, EJ, Montgomery, H, Streicher, K

    Foilsithe / Cruthaithe 2023
    Journal article
  3. 3
    Efficacy and safety of intramuscular administration of tixagevimab-cilgavimab for early outpatient treatment of COVID-19 (TACKLE): a phase 3, randomised, double-blind, placebo-controlled trial

    Efficacy and safety of intramuscular administration of tixagevimab-cilgavimab for early outpatient treatment of COVID-19 (TACKLE): a phase 3, randomised, double-blind, placebo-cont... de réir Montgomery, H, Hobbs, FDR, Padilla, F, Arbetter, D, Templeton, A, Seegobin, S, Kim, K, Campos, JAS, Arends, RH, Brodek, BH, Brooks, D, Garbes, P, Jimenez, J, Koh, GCKW, Padilla, KW, Streicher, K, Viani, RM, Alagappan, V, Pangalos, MN, Esser, MT, TACKLE Study Group

    Foilsithe / Cruthaithe 2022
    Journal article

Uirlisí cuardaigh: